Prescription Required.Why?
A sodium-glucose co-transporter-2 (sglt2) inhibitor that helps your kidneys remove excess sugar from your blood into your urine.
A biguanide that lowers blood sugar by improving insulin sensitivity and decreasing glucose production in the liver.
A dipeptidyl peptidase-4 (dpp-4) inhibitor that enhances the release of insulin and reduces the production of glucagon, a hormone that raises blood sugar.
Treatment of type 2 diabetes mellitus in adults when metformin alone or in combination with another oral antidiabetic agent does not provide adequate glycemic control.
This triple combination drug works synergistically to manage blood sugar levels. Dapagliflozin increases glucose excretion in urine, metformin improves insulin sensitivity and reduces hepatic glucose production, and teneligliptin enhances incretin effects, leading to improved glucose control.
Store at room temperature, away from direct sunlight and moisture. Keep out of reach of children.
Dosage should be determined by your doctor based on your individual needs and response to treatment.
It is usually taken orally once daily with or without food.
Follow your doctor's instructions carefully; do not alter the dosage or frequency without consulting your physician.
Hypoglycemia (low blood sugar)
Urinary tract infections
Genital yeast infections
Nausea
Vomiting
Diarrhea
Constipation
Headache
Fatigue
Weight loss
Ketoacidosis (rare, but serious)
Severe allergic reactions (rare)
Limit alcohol intake as it can increase the risk of hypoglycemia and lactic acidosis (with metformin).
Be cautious as hypoglycemia can impair alertness and concentration.
Not recommended during pregnancy and breastfeeding. Consult your doctor immediately if pregnancy is planned or occurs.
Not indicated for use in children.
Requires dosage adjustment or contraindicated in patients with severe kidney impairment. Regular kidney function monitoring is crucial.
Requires careful monitoring in patients with liver impairment. Dosage adjustment may be necessary.
Consult your doctor or pharmacist for detailed information and references to package inserts and clinical trials.
Always refer to the latest prescribing information from the manufacturer.
